According to Jabbar et al. Of the University of Gothenburg in Sweden, targeted mass spectrometry based on only three biomarkers of cyst fluid can highly accurately identify and evaluate the possibility of pancreatic cysts develo..
Investigative research suggests that diet may affect the risk of pancreatic cancer. The study investigated the effect of a low-fat diet on the incidence of pancreatic cancer.The Women's Healthy Diet Changes (WHI-DM) trial is a ra..
Pancreatic cancer is a malignant tumor with extremely high degree of harm, and pancreatic cancer will have different signs at different periods. Although pancreatic cancer is difficult to be diagnosed early, if you have a certai..
Pancreatic cancer: diagnosisIf the doctor suspects that someone has pancreatic cancer, he will first ask the patient's medical history, family medical history, and check for signs of the disease. The following tests can be used t..
In the fall of 2015, 44-year-old Doron Broman was diagnosed with pancreatic cancer -and was surprised to find that his pancreatic cancer had metastasized to a large tumor on the liver. Faced with a survival period of only a few..
Early diagnosis of pancreatic cancer is difficult and lacks specific drugs. Recently, researchers from France and Spain have discovered that a substance that has been used to treat anxiety can interfere with the development of ..
Pancreatic cancer Pancreatic cancer is a malignant tumor of the digestive tract that is highly malignant and difficult to diagnose and treat. About 90% is ductal adenocarcinoma that originates in the ductal epithelium. Its morbi..
Pancreatic cancer is a malignant tumor of the digestive tract that is highly malignant and difficult to diagnose and treat. It is hailed as the "king of cancer" by the medical profession. The 5-year survival rate is <1%, which ..
Pancreatic cancer is currently one of the most deadly and chemotherapy-resistant cancers. Recently, cancer researchers in Australia have developed a very promising nanomedical method that will improve the treatment of pancreati..
Pancreatic cancer targeted drug, pancreatic cancer BRCA mutation targeted drug olaparib (Olaparib, Liprot Lynparza) received FDA expert support Due to the strong invasiveness and limited treatment of pancreatic cancer, no breakth..